Skip to content

Core Molding Technologies CMT Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$58.6M-4.7%
Gross profit$12.0M+1.7%
Operating income$764.0K-73.1%
Net income$605.0K-72.3%
EPS (diluted)$0.07-72.0%

Balance sheet

See full
Cash & equivalents$23.5M-47.1%
Total debt$35.0M+34.4%
Total equity$158.2M+5.6%
Total assets$242.4M+8.4%

Cash flow

See full
Operating cash flow-$9.2M-251%
CapEx$3.8M+114%
Free cash flow-$13.0M-401%

Valuation

See full
Market cap$200.81M+36.0%
Enterprise value$212.29M+63.5%
P/E20.9×+5.1×
P/S0.7×+0.2×

Profitability

See full
Gross margin17.6%-0.5pp
Operating margin4.5%-0.7pp
Net margin3.5%-0.6pp
FCF margin4.6%-3.8pp

Returns & leverage

See full
Return on equity6.2%-1.8pp
Debt / equity0.2×0.0×
Current ratio2.4×-0.1×